Navigation Links
Terramera PlantScience Acquires Plasma Power
Date:9/3/2014

Vancouver, B.C. (PRWEB) September 03, 2014

Ag/Bio Tech company Terramera PlantScience announced today the acquisition of Plasma Power, an India-based manufacturer of Cold Pressed Neem Oil and other ecologically friendly products for use in agriculture, human health and cosmetic applications. Plasma Power, headquartered in Chennai India, produces a range of products for use agricultural crop protection including the only US EPA registered cold pressed neem oil for use as a pesticide. Plasma Power’s Cold Pressed Neem Oil is the active ingredient in Terramera’s leading biopesticides which include Proof® plant-based insecticides, and CIRKIL® professional products.

Plasma Power was founded in 1987 and has been focusing on the development of Neem and other natural products since 1996. They have perfected the process of cold pressed Neem Oil extraction and hold its patent. Their products include certified organic Cold Pressed Neem oil, Neem cake, Karanja oil and Karanja cake. Terramera will continue Plasma Power’s operation in India with the existing staff and facilities, serving the Plasma’s current global customer base and will invest to grow the business aggressively.

“The acquisition of Plasma gives Terramera PlantScience security with the only EPA registered source of Cold Pressed Neem Oil and guarantees supply of the key active ingredient in our current biopesticide products,” said Karn Manhas, CEO and founder of Terramera. “It also provides a profitable going concern with a global customer base, and an opportunity to expand use of neem products globally—both through Terramera and with Plasma’s customers—for biopesticides, health and cosmetic applications.”

“Terramera PlantScience has active field trials and a solid pipeline of products in development using Cold Pressed Neem Oil from Plasma Power,” said Manhas, “this acquisition will allow Terramera to accelerate development and regulatory approval processes through this vertical integration of our active ingredient source.”

This acquisition will allow Terramera PlantScience to accelerate development and production of neem, neem products, and better biopesticides. The company will strive to increase the supply of the highest standard of quality cold-pressed neem around the world for all uses.

Media Contacts:

Karn Manhas, CEO
Terramera PlantScience
karn@terrramera.com
(800) 597-9509
(604) 343-5553    

Maxwell Samuel, Country Manager
Terramera Biosciences (India) Private Limited
maxwell@plasmaneem.com

About Terramera PlantScience: Terramera is the leader in developing revolutionary plant-based products that are a highly effective, minimal-toxicity means of pest management. The company’s flagship products include Proof® and CIRKIL®, EPA-registered biopesticides for control of bed bugs and other household pests. Terramera’s product pipeline includes biopesticides for agricultural use in a variety of crops and applications for bee health. Terramera was highlighted as a leader with potential to dominate the biopesticides market in a recent report by LUX research, an independent research and advisory firm which identified biopesticides as a “hot” industry, predicting growth into a multi billion-dollar market. Terramera is a Vancouver, Canada based company founded in 2009 with the mission to provide safe and innovative pest management products for every person and family. For more information about Terramera, visit our websites at http://www.terramera.com and at http://www.plasmaneem.com

Read the full story at http://www.prweb.com/releases/2014/08/prweb12133547.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. PlantCellCulture.com Launched by DianaPlantSciences to Educate Industry and Consumers About Benefits of Plant Cell Culture Technology
2. Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen
3. SP Industries Acquires Bel-Art Products
4. Kainos Capital Acquires Slim-Fast From Unilever
5. WaferGen Bio-systems Acquires a Leading Next-Generation Sequencing (NGS) Library Preparation Business and Announces Changes to its Board of Directors
6. Decision Resources Group Acquires Relay Technology Management
7. Neogen acquires Chem-Tech
8. Arsenal Capital Partners Acquires Leading Model-Based Drug Development Company Certara
9. NSF International Acquires Brazil’s Bioensaios Analysis and Environmental Consultancy Ltd., a Leading Analytical Laboratory
10. Neogen acquires Prima Tech
11. RGF Environmental Group Acquires AFL Industries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... LONDON , Feb. 9, 2016 /PRNewswire/ ... (PTP1B) Inhibitors-Pipeline Insights, 2016", report provides in ... their development activities around the Protein-Tyrosine Phosphatase ... the product profiles in various stages of ... Phase II, Phase III and Preregistration. Report ...
(Date:2/8/2016)... Should antibiotic bone cement products be used ... infection after standard total hip or knee replacement surgery? ... have been fielding a lot lately. "Antibiotic ... --> "Antibiotic Bone Cement: Fighting ... --> While there isn,t a simple answer, ECRI ...
(Date:2/8/2016)... , February 8, 2016 ... Oncology Private Limited, an innovation-driven oncology company developing ... and less toxic, today announced that chairman emeritus ... has invested in the company as part of ... round, joining existing investors Navam Capital and Aarin ...
(Date:2/8/2016)... ... 2016 , ... Thomas J. Todorow has joined the University ... Corporate Services and the Chief Financial Officer at The Children’s Hospital of Philadelphia ... Care Contracting, Supply Chain, and Investments. , Prior to joining CHOP and The ...
Breaking Biology Technology:
(Date:2/3/2016)... --> --> Fourth quarter ... up 1,187% compared with fourth quarter of 2014. Gross margin ... (loss: 30.0). Earnings per share increased to SEK 6.39 (loss: ... (neg: 74.7). , --> --> ... 2,900.5 M (233.6), up 1,142% compared with 2014. Gross margin ...
(Date:2/2/2016)... , Feb. 2, 2016  BioMEMS devices ... primarily focused on medical screening and diagnostic ... parameters. Wearable devices that facilitate and assure ... of movement are being bolstered through new ... biomedical signal acquisition coupled with wireless connectivity ...
(Date:2/2/2016)... RESTON, Va. , Feb. 2, 2016 /PRNewswire/ ... contract award from the U.S. Army Research Office ... extend the range and sensitivity of the company,s ... DoD,s Past Accounting Mission and, more generally, defense-related ... its DNA phenotyping capabilities (predicting appearance and ancestry ...
Breaking Biology News(10 mins):